NCT01707745Unknown不适用
Efficacy and Safety of Intravitreal Bevacizumab for Threshold ROP.
Sivakami A Pai1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2010年1月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Regression Of ROP
研究概览
简要总结
Prospective study to evaluate the efficacy and safety of intravitreal bevacizumab In retinopathy of prematurity (ROP).
Bevacizumab 0.75 mg in 0.03 ml was given to stage 2+ or stage 3+ ROP in Zone I or Zone II.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 32 Weeks 至 42 Weeks（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •stage 2+ or stage 3+ Retinopathy of prematurity in Zone I or Zone II.
- •Informed written consent by parents or guardian.
排除标准
- •Refusal to give consent Critically ill neonates.
结局指标
主要结局
Regression Of ROP
时间窗: Minimum 6 months follow up after intravitreal Avastin
次要结局
- Recurrence of ROP(minimum 6 months of follow up.)
研究者
Sivakami A Pai
Doctor
Dubai Health Authority
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin)diabetic retinopathy central retinal vein occulusion, neovascular glaucomaJPRN-UMIN000012248ational Center for Global Health and Medicine, Kohnodai Hospital20
已完成
4 期
Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyNCT01025934University of Campania "Luigi Vanvitelli"
已完成
4 期
Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic RetinopathyProliferative Diabetic RetinopathyDiabetic Traction Retinal DetachmentVitreous HemorrhageNCT01854593Nihon University69
Unknown
3 期
Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)Diabetic RetinopathyNCT00370721Shahid Beheshti University of Medical Sciences
Unknown
2 期
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of PrematurityRetinopathy of PrematurityNCT00622726The University of Texas Health Science Center, Houston150